Thyrocare Technologies Limited
Simbol: THYROCARE.BO
BSE
603.8
INRTržna cena danes
50.3318
Razmerje P/E
0.9063
Razmerje PEG
31.97B
Kapaciteta MRK
- 0.00%
Donos DIV
Thyrocare Technologies Limited (THYROCARE-BO) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1400.7 | 1388.4 | 1176.9 | |||||||||
balance-sheet.row.short-term-investments | 0 | 1223 | 1252.1 | 1044.9 | |||||||||
balance-sheet.row.net-receivables | 0 | 856.7 | 944.8 | 513.5 | |||||||||
balance-sheet.row.inventory | 0 | 276.7 | 245.3 | 233.6 | |||||||||
balance-sheet.row.other-current-assets | 0 | 53.2 | 112.8 | 28.4 | |||||||||
balance-sheet.row.total-current-assets | 0 | 2729.4 | 2700.2 | 2404.4 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1944.3 | 1867.9 | 1600.9 | |||||||||
balance-sheet.row.goodwill | 0 | 1002.8 | 1002.8 | 1002.8 | |||||||||
balance-sheet.row.intangible-assets | 0 | 7.9 | 8.3 | 9.7 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1010.7 | 1011.1 | 1012.5 | |||||||||
balance-sheet.row.long-term-investments | 0 | 223.1 | 243.8 | 270.7 | |||||||||
balance-sheet.row.tax-assets | 0 | 122.7 | 64.9 | 56.3 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 297 | 188.7 | 113.2 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 3597.8 | 3376.4 | 3053.6 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 6327.2 | 6076.6 | 5458 | |||||||||
balance-sheet.row.account-payables | 0 | 239.9 | 165.3 | 250.1 | |||||||||
balance-sheet.row.short-term-debt | 0 | 71.9 | 50 | 30.4 | |||||||||
balance-sheet.row.tax-payables | 0 | 18.3 | 18.3 | 18.6 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 161.2 | 157 | 54.5 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 91.9 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 398.4 | 336.5 | 312.5 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 204 | 165.7 | 234.2 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 233.1 | 207 | 84.9 | |||||||||
balance-sheet.row.total-liab | 0 | 975 | 810.9 | 1185.2 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 529.3 | 529 | 528.7 | |||||||||
balance-sheet.row.retained-earnings | 0 | 3434.2 | 3568.8 | 2599.2 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1255.9 | 1244.1 | 1225.8 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 123.6 | -76.2 | -80.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5343 | 5265.7 | 4272.8 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6327.2 | 6076.6 | 5458 | |||||||||
balance-sheet.row.minority-interest | 0 | 9.2 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 5352.2 | 5265.7 | 4272.8 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 221 | 209.2 | 211 | |||||||||
balance-sheet.row.total-debt | 0 | 233.1 | 207 | 84.9 | |||||||||
balance-sheet.row.net-debt | 0 | 55.4 | 70.7 | -47.1 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 874.1 | 2279 | 1525.4 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 387.1 | 338.7 | 302.8 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | -247.4 | -731.2 | -522.2 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 211.7 | 23.2 | 16.8 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | 57.9 | -792.2 | -176.5 | |||||||||||
cash-flows.row.account-receivables | 0 | -14.3 | -587.2 | -288.1 | |||||||||||
cash-flows.row.inventory | 0 | -31.4 | -11.7 | -27.4 | |||||||||||
cash-flows.row.account-payables | 0 | 74.2 | -84.8 | 31.5 | |||||||||||
cash-flows.row.other-working-capital | 0 | 29.4 | -108.5 | 107.5 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 9.7 | 16.6 | 1 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -436.5 | -378.3 | -266.9 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 30.2 | 42.5 | 42.5 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | -1919.9 | -1730 | -1361.1 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1932.5 | 1593.5 | 1042.1 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 3.8 | 236.6 | 56.8 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -389.9 | -235.7 | -486.6 | |||||||||||
cash-flows.row.debt-repayment | 0 | -55.3 | -53.8 | -25 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0.3 | 0.3 | 0.3 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | -55.3 | -53.8 | -62.6 | |||||||||||
cash-flows.row.dividends-paid | 0 | -793.5 | -793.1 | -528.4 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 42 | 6.3 | -0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -861.8 | -894.1 | -615.8 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | -2.5 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 41.4 | 4.3 | 44.9 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 177.7 | 136.3 | 132 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 136.3 | 132 | 87.1 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 1293.1 | 1134.1 | 1147.3 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -436.5 | -378.3 | -266.9 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 856.6 | 755.8 | 880.4 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 5266.7 | 5888.6 | 4946.2 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 1632.3 | 1696.9 | 1639 | |||||||||
income-statement-row.row.gross-profit | 0 | 3634.4 | 4191.7 | 3307.2 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | 4.4 | 18 | 21.2 | |||||||||
income-statement-row.row.operating-expenses | 0 | 2788.2 | 2173.1 | 1895.9 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 4420.5 | 3870 | 3534.9 | |||||||||
income-statement-row.row.interest-income | 0 | 13.8 | 7.1 | 7.9 | |||||||||
income-statement-row.row.interest-expense | 0 | 23.5 | 23.7 | 8.7 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.4 | 227.9 | 61.8 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | 4.4 | 18 | 21.2 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -0.4 | 227.9 | 61.8 | |||||||||
income-statement-row.row.interest-expense | 0 | 23.5 | 23.7 | 8.7 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 387.1 | 338.7 | 302.8 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | 865.5 | 2044.2 | 1455.9 | |||||||||
income-statement-row.row.income-before-tax | 0 | 885.9 | 2277.2 | 1524.7 | |||||||||
income-statement-row.row.income-tax-expense | 0 | 242.3 | 515.8 | 393.2 | |||||||||
income-statement-row.row.net-income | 0 | 643.6 | 1761.4 | 1131.5 |
Pogosto zastavljeno vprašanje
Kaj je Thyrocare Technologies Limited (THYROCARE.BO) skupna sredstva?
Thyrocare Technologies Limited (THYROCARE.BO) skupna sredstva so 6327200000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.708.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 16.845.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.118.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.151.
Kaj je Thyrocare Technologies Limited (THYROCARE.BO) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 643600000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 233100000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 2788200000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.